Trials / Completed
CompletedNCT04133844
Evaluation of Antithrombin Deficiency in Patients of Intensive Care Unit Placed on Extracorporeal Membrane Oxygenation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, monocentric, non-interventional study in patients placed on extracorporeal membrane oxygenation (ECMO)
Detailed description
Our hypothesis is that ECMO initiation is responsible for a severe decrease of antithrombin level in a high proportion of patients who develop heparin resistance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sample | Blood sample collection from a peripheral catheter at ECMO initiation (H0), then 2h, 6h, 12h, 24h and daily from day 2 to day 7 or at ECMO discontinuation |
Timeline
- Start date
- 2020-05-05
- Primary completion
- 2021-05-18
- Completion
- 2021-05-18
- First posted
- 2019-10-21
- Last updated
- 2021-06-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04133844. Inclusion in this directory is not an endorsement.